We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Exhibits New Hematology Analyzer in Middle East

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: The DxH 900 hematology analyzer (Photo courtesy of Beckman Coulter).
Image: The DxH 900 hematology analyzer (Photo courtesy of Beckman Coulter).
Beckman Coulter (Brea, CA, USA) exhibited its DxH 900 hematology analyzer at MedLab Middle East, an international platform for laboratory management and medicine that brought together more than 700 exhibitors and over 35,000 professionals. MedLab Middle East 2019 took place at the Dubai International Convention and Exhibition Centre, Dubai, UAE, from February 4-7, 2019.

At the event, Beckman Coulter displayed its DxH 900 hematology analyzer, which allows mid- to high-volume clinical laboratories to perform complete blood count and white blood cell differential tests with minimal repeats. The DxH 900 analyzer offers advanced technologies to support patient care, by delivering the right results the first time. Foundational to the system are its core technologies, including the enhanced Coulter Principle, VCS 360 and DataFusion. These features offer high-resolution analysis of cells in their near-native states, providing a precise cellular assessment for excellent red blood cell, platelet and white blood cell test results on the first pass.

The DxH 900 analyzer demonstrates industry-leading 93% first-pass throughput, providing accurate flagging and reducing the number of slide reviews. This helps to generate reportable results as quickly as possible, reducing the time, supplies and costs that may be required for systems with higher repeat rates. Adding to this is the analyzer's lean reagent portfolio, which includes four reagents compared to 11 reagents required by other analyzers. Further, the DxH 900 features one of the smallest footprints in its class, making it highly efficient in utilization of laboratory space.

Gold Supplier
SARS-CoV-2 IgG ELISA Test
SARS-CoV-2 IgG ELISA Kit
New
Gold Supplier
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
New
Silver Supplier
Urea Breath Test
13C-Urea Breath Test
New
Silver Supplier
CLIA Microwell Strip Luminometer
LumiStat 4900

Print article

Channels

Molecular Diagnostics

view channel
Image: A new blood test could noninvasively and inexpensively detect colorectal cancer (Photo courtesy of Pexels)

Novel Blood Test Could Detect Early-Onset Colorectal Cancer

Colorectal cancer is the fourth most common cancer, according to the U.S. Centers for Disease Control and Prevention. The rate of colon or rectal cancers in people younger than 50 years old has been on... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.